tiprankstipranks
Trending News
More News >
Laekna, Inc. (HK:2105)
:2105
Hong Kong Market

Compare Laekna, Inc. (2105) vs. Competitors

Compare
4 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Laekna, Inc.
HK$13.70
HK$5.75B
-19.45
48.11%
0 Buy
0 Hold
0 Sell
Moderate Buy
Kindstar Globalgene Technology, Inc.
HK$1.17
HK$1.26B
-10.19
2.54%
Ocumension Therapeutics
HK$7.55
HK$6.03B
-20.72
70.28%
TOT BIOPHARM International Co. Ltd.
HK$2.50
HK$3.18B
392.38
116.84%
Lepu Biopharma Co. Ltd. Class H
HK$4.98
HK$8.66B
-41.39
70.70%
Broncus Holding Corp.
HK$2.36
HK$1.09B
-8.51
228.57%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:2105
Laekna, Inc.
13.70
4.89
55.51%
HK:9960
Kindstar Globalgene Technology, Inc.
1.21
0.06
5.22%
HK:1477
Ocumension Therapeutics
7.39
3.31
81.13%
HK:1875
TOT BIOPHARM International Co. Ltd.
4.12
2.28
123.91%
HK:2157
Lepu Biopharma Co. Ltd. Class H
4.66
1.77
61.25%
HK:2216
Broncus Holding Corp.
2.07
1.47
245.00%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts